You are seeing this message because your Web browser does not support basic Web standards. Find out more about why this message is appearing and what you can do to make your experience on this site better.


ABOUT ARCHIVES
Advanced Search

Welcome   | My Account | E-mail Alerts | Access Rights | Sign In


  Vol. 136 No. 4, April 2000 TABLE OF CONTENTS
  Archives
  •  Online Features
  Correspondence
 This Article
 •Full text
 •PDF
 •Send to a friend
 • Save in My Folder
 •Save to citation manager
 •Permissions
 Citing Articles
 •Citing articles on HighWire
 •Citing articles on ISI (2)
 •Contact me when this article is cited
 Related Content
 •Similar articles in this journal

Fecal Porphyrin Measurements Are Crucial for Adequate Screening for Porphyrinopathy

Since this article does not have an abstract, we have provided the first 150 words of the full text and any section headings.

From a survey of Spanish villagers aged 15 or older who lived near an organochlorine chemical plant from which relatively high air levels of hexachlorobenzene emanated, Herrero et al1 have concluded that such exposures were insufficient to trigger significant alterations of porphyrin metabolism. That conclusion was not really justified, being based on only urine porphyrin measurements. Fecal porphyrin measurements are crucial for adequate screening for porphyrinopathy.2-3 Failure to screen with fecal porphyrin measurements will miss about half the cases of porphyria cutanea tarda (PCT). Normal urine porphyrins are no guarantee that abnormal fecal porphyrins will not be found. The same limited urinary porphyrin test was done for most if not all cases tested in the 1955-1959 Turkish porphyria epidemic,4 but that investigation did not attempt to identify safe limits of exposure, as did this one. The Spanish study significantly underestimated the effects of exposure by failure of adequate screening, so . . . [Full Text of this Article]



THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES

Acute Porphyrias: A Case Report and Review
Gonzalez-Arriaza and Bostwick
Am. J. Psychiatry 2003;160:450-459.
FULL TEXT  





HOME | CURRENT ISSUE | PAST ISSUES | TOPIC COLLECTIONS | CME | SUBMIT | SUBSCRIBE | HELP
CONDITIONS OF USE | PRIVACY POLICY | CONTACT US | SITE MAP
 
© 2000 American Medical Association. All Rights Reserved.